Strenza Plus

Strenza Plus is an ophthalmic convenience pack developed by Brisk Pharmaceuticals specifically for post-surgical recovery following eye procedures. The pack contains three separate, FDA-approved medications: moxifloxacin hydrochloride ophthalmic solution 0.5%, bromfenac ophthalmic solution 0.09%, and prednisolone acetate ophthalmic suspension 1%. This combination provides a comprehensive therapeutic regimen to address the primary concerns of post-operative care: moxifloxacin serves as a broad-spectrum fluoroquinolone antibiotic to prevent bacterial infection; bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation; and prednisolone acetate is a potent corticosteroid that further manages inflammatory responses. By providing these medications in a single convenience pack, the product aims to improve patient compliance and streamline the recovery process after ophthalmic surgery.

Brand names

Strenza Plus

Other names

Strenza Plus-Brisk Pharmaceuticals-drug convenience pack-ophthalmic-ophthalmic post-surgical recovery